Methods for the treatment of IL-1β related diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 20, 2015
Issued Date -
N/A
app pub date -
Sep 30, 2013
filing date -
Dec 20, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1β antibody or fragment thereof.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully